ECHOCARDIOGRAPHIC FINDINGS AND ITS CORRELATION WITH THE SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A TERTIARY CARE HOSPITAL AT NORTH KERALA: A CROSS-SECTIONAL STUDY

Main Article Content

Vidhiyasagaran J
Pallavi Kulkarni
 James P.T
Manimekalai K

Keywords

Chronic obstructive pulmonary disease, cardiovascular disease, spirometry, echocardiography

Abstract

Chronic obstructive pulmonary disease (COPD) and cardiovascular diseases (CVD) are more frequently associated and their coexistence worsen the prognosis of the condition. The irreversible airflow obstruction in COPD, leads to persistent hypoxia and cardiovascular damage. Our objective was to assess the cardiac changes secondary to COPD by echocardiography and to correlate the echo findings with pulmonary function parameters across the severity of COPD. A total of 120 patients were selected and the severity was graded by Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines using spirometry. All patients were subjected to echocardiographic evaluation. On echocardiographic evaluation, 60.83% patients had abnormal findings. Majority of cases had pulmonary hypertension (PH). Severe grade of PH was present in severe (33.33%) and very severe (66.67%) stages of COPD. There was a significant association (p <0.05) between the severity of COPD and frequency of PH, cor pulmonale and tricuspid regurgitation (TR). The frequency of left ventricular systolic dysfunction (LVSD) and left ventricular diastolic dysfunction (LVDD) were 12.5% and 55.83% respectively. There was a significant(p<0.05) negative correlation between echo parameters (cor pulmonale, TR degree) and spirometry parameters. To conclude, the prevalence of cardiac dysfunction showed a liner relationship with the severity of COPD, especially cor pulmonale and TR, with a statistical significance (p<0.05). Echocardiography detects cardiovascular abnormality in COPD patients at the subclinical stage and helps in the improvement of health care.

Abstract 175 | PDF Downloads 98

References

1. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10. PMID: 35279265; PMCID: PMC9050565.
2. Verma A, Gudi N, Yadav UN, Roy MP, Mahmood A, Nagaraja R, Nayak P. Prevalence of COPD among population above 30 years in India: A systematic review and meta-analysis. J Glob Health. 2021 Aug 21; 11:04038. doi: 10.7189/jogh.11.04038. PMID: 34484706; PMCID: PMC8397327.
3. Rodrigues SO, Cunha CMCD, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals (Basel). 2021 Sep 26;14(10):979. doi: 10.3390/ph14100979. PMID: 34681202; PMCID: PMC8539950.
4. Trinkmann F, Saur J, Borggrefe M, Akin I. Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)-Current Considerations for Clinical Practice. J Clin Med. 2019 Jan 10;8(1):69. doi: 10.3390/jcm8010069. PMID: 30634565; PMCID: PMC6352261.
5. Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018 Jan-Dec; 12:1753465817750524. doi: 10.1177/1753465817750524. PMID: 29355081; PMCID: PMC5937157.
6. Papaporfyriou A, Bartziokas K, Gompelmann D, Idzko M, Fouka E, Zaneli S, Bakakos P, Loukides S, Papaioannou AI. Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy. Life (Basel). 2023 May 31;13(6):1299. doi: 10.3390/life13061299. PMID: 37374082; PMCID: PMC10301030.
7. Chuang ML. Combining Dynamic Hyperinflation with Dead Space Volume during Maximal Exercise in Patients with Chronic Obstructive Pulmonary Disease. J Clin Med. 2020 Apr 15;9(4):1127. doi: 10.3390/jcm9041127. PMID: 32326507; PMCID: PMC7231163.
8. Karnati S, Seimetz M, Kleefeldt F, Sonawane A, Madhusudhan T, Bachhuka A, Kosanovic D, Weissmann N, Krüger K, Ergün S. Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target. Front Cardiovasc Med. 2021 Apr 12; 8:649512. doi: 10.3389/fcvm.2021.649512. PMID: 33912600; PMCID: PMC8072123.
9. Schroder J, Prescott E. Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients *-with Angina and No Obstructive Coronary Artery Disease. Front Cardiovasc Med. 2021 Oct 29; 8:723542. doi: 10.3389/fcvm.2021.723542. PMID: 34778394; PMCID: PMC8585781.
10. Hur DJ, Sugeng L. Non-invasive Multimodality Cardiovascular Imaging of the Right Heart and Pulmonary Circulation in Pulmonary Hypertension. Front Cardiovasc Med. 2019 Mar 14; 6:24. doi: 10.3389/fcvm.2019.00024. PMID: 30931315; PMCID: PMC6427926.
11. Mandoli GE, Sciaccaluga C, Bandera F, Cameli P, Esposito R, D'Andrea A, Evola V, Sorrentino R, Malagoli A, Sisti N, Nistor D, Santoro C, Bargagli E, Mondillo S, Galderisi M, Cameli M; Working group of Echocardiography of Italian Society of Cardiology (SIC). Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings. Heart Fail Rev. 2021 Mar;26(2):263-275. doi: 10.1007/s10741-020-10014-4. PMID: 32860180; PMCID: PMC7895796.
12. Nasir SA, Singh S, Fotedar M, Chaudhari SK, Sethi KK. Echocardiographic Evaluation of Right Ventricular Function and its Role in the Prognosis of Chronic Obstructive Pulmonary Disease. J Cardiovasc Echogr. 2020 Jul-Sep;30(3):125-130. doi: 10.4103/jcecho.jcecho_10_20. Epub 2020 Nov 9. PMID: 33447502; PMCID: PMC7799065.
13. Mohammed RA, Mohamed LA, Abdelsalam EM, Maghraby HM, Elkenany NM, Nabawi OE, Sultan I. Assessment of Cardiac Dysfunction in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Cross-Sectional Study. Cureus. 2023 May 29;15(5): e39629. doi: 10.7759/cureus.39629. PMID: 37388620; PMCID: PMC10303266.
14. Wu J, Wang J, Wang Y, Fan W, Li H, Wu H. Echocardiography E/A Abnormality is Associated with the Development of Primary Left Ventricle Remodeling in Middle-Aged and Elderly Women: A Longitudinal Study. Clin Interv Aging. 2023 Apr 18; 18:629-638. doi: 10.2147/CIA.S399996. PMID: 37096218; PMCID: PMC10122471.
15. Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India. 2011 Apr;28(2):105-9. doi: 10.4103/0970-2113.80321. PMID: 21712919; PMCID: PMC3109831.
16. Barjaktarevic I, Campos M. Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know. Ther Adv Chronic Dis. 2021 Jul 29;12_suppl:20406223211010172. doi: 10.1177/20406223211010172. PMID: 34408831; PMCID: PMC8367208.
17. Ortiz-Quintero B, Martínez-Espinosa I, Pérez-Padilla R. Mechanisms of lung damage and development of COPD due to household biomass-smoke exposure: inflammation, oxidative stress, microRNAs, and gene polymorphisms. Cells. 2022 Dec 23;12(1):67. doi: 10.3390/cells12010067. PMID: 36611860; PMCID: PMC9818405.
18. Yao S, Zeng L, Wang F, Chen K. Obesity Paradox in Lung Diseases: What Explains It? Obes Facts. 2023;16(5):411-426. doi: 10.1159/000531792. Epub 2023 Jul 18. PMID: 37463570; PMCID: PMC10601679.
19. Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management. Semin Respir Crit Care Med. 2015 Aug;36(4):575-91. doi: 10.1055/s-0035-1556063. Epub 2015 Aug 3. PMID: 26238643; PMCID: PMC5004772.
20. Ramachandran P, Devaraj U, Patrick B, Saxena D, Venkatnarayan K, Louis V, Krishnaswamy UM, D'souza GA. Ultrasonographic assessment of skeletal muscle mass and diaphragm function in patients with chronic obstructive pulmonary disease: A case-control study. Lung India. 2020 May-Jun;37(3):220-226. doi: 10.4103/lungindia.lungindia_103_19. PMID: 32367843; PMCID: PMC7353944.
21. Nasir SA, Singh S, Fotedar M, Chaudhari SK, Sethi KK. Echocardiographic Evaluation of Right Ventricular Function and its Role in the Prognosis of Chronic Obstructive Pulmonary Disease. J Cardiovasc Echogr. 2020 Jul-Sep;30(3):125-130. doi: 10.4103/jcecho.jcecho_10_20. Epub 2020 Nov 9. PMID: 33447502; PMCID: PMC7799065.
22. Khalid K, Padda J, Komissarov A, Colaco LB, Padda S, Khan AS, Campos VM, Jean-Charles G. The Coexistence of Chronic Obstructive Pulmonary Disease and Heart Failure. Cureus. 2021 Aug 23;13(8): e17387. doi: 10.7759/cureus.17387. PMID: 34584797; PMCID: PMC8457262.
23. Kubota Y, Asai K, Murai K, Tsukada YT, Hayashi H, Saito Y, Azuma A, Gemma A, Shimizu W. COPD advances in left ventricular diastolic dysfunction. Int J Chron Obstruct Pulmon Dis. 2016 Mar 29; 11:649-55. doi: 10.2147/COPD.S101082. PMID: 27099482; PMCID: PMC4820215.
24. Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K. Left ventricular dysfunction in COPD without pulmonary hypertension. PLoS One. 2020 Jul 16;15(7): e0235075. doi: 10.1371/journal.pone.0235075. PMID: 32673327; PMCID: PMC7365599.
25. Yogeswaran A, Kuhnert S, Gall H, Faber M, Krauss E, Rako ZA, Keranov S, Grimminger F, Ghofrani HA, Naeije R, Seeger W. Relevance of cor pulmonale in COPD with and without pulmonary hypertension: a retrospective cohort study. Frontiers in cardiovascular medicine. 2022 Feb 16; 9:826369.